摘要 |
The invention provides a compound of the formula: wherein A is selected from N, CH and CR; R is selected from halogen, optionally substituted alkyl, aralkyl and aryl, OH, NH<SUB>2</SUB>, NHR<SUP>1</SUP>, NR<SUP>1</SUP>R<SUP>2 </SUP>and SR<SUP>3</SUP>; R<SUP>1</SUP>, R<SUP>2 </SUP>and R<SUP>3 </SUP>are each optionally substituted alkyl, aralkyl or aryl groups; B is selected from NH<SUB>2 </SUB>and NHR<SUP>4</SUP>; R<SUP>4 </SUP>is an optionally substituted alkyl, aralkyl or aryl group; X is selected from H, OH and halogen; Z is selected from H, Q, SQ and OQ; Q is an optionally substituted alkyl, aralkyl or aryl group; or a tautomer, a pharmaceutically acceptable salt, an ester, or a prodrug thereof; with the proviso that the stereochemistry of the aza-sugar moiety is D-ribo or 2'-deoxy-D-erythro-; pharmaceutical compositions comprising said compound; and methods of treatment using said compound.
|